Systemic Therapy for Patients With Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

Overview of attention for article published in Journal of Clinical Oncology, May 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (98th percentile)
High Attention Score compared to outputs of the same age and source (97th percentile)

Mentioned by

news: 10 news outlets
policy: 2 policy sources
twitter: 32 X users
patent: 3 patents

weibo: 1 weibo user
facebook: 3 Facebook pages
f1000: 1 research highlight platform

Citations

dimensions_citation: 303 Dimensions

Readers on

mendeley: 429 Mendeley

Summary News Policy documents X Patents Weibo Facebook Research highlights Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

Treatment of HER2 positive cancers

Grant US-11666572-B2

United States of America

METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN COMBINATION WITH…

Application WO-2021080983-A1

World Intellectual Property Organisation (WIPO)

TREATMENT OF HER2 POSITIVE CANCERS

Application WO-2018201016-A1

World Intellectual Property Organisation (WIPO)